MedTrace Logo

A Feasibility Trial of Sisterhood 2.0

NCT04388696 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 246

Last updated 2020-05-18

No results posted yet for this study

Summary

This pilot quasi-experimental community based trial examines the feasibility of a sexual violence and adolescent relationship abuse prevention program for girls aged 14-19. Feasibility is assessed through participant attendance, retention and program satisfaction measures and interviews are conducted at baseline, end of program and 3 month follow up (endline) about participant experiences.

Conditions

  • Adolescent Behavior
  • Violence in Adolescence
  • Group, Peer
  • Violence, Non-accidental
  • Violence, Sexual
  • Violence, Physical
  • Violence, Domestic
  • Emotional Abuse
  • Coping Skills
  • Communication, Personal

Interventions

BEHAVIORAL

Sisterhood 2.0

The Sisterhood 2.0 curriculum was adapted from Program M, created in 2006 by Promundo to address health and empowerment of young women aged 15-24. The curriculum engages young women in questioning rigid and non-equitable stereotypes about masculinity and femininity and how they affect both women's and men's health and well-being.

Sponsors & Collaborators

  • Department Human Services, Pennsylvania

    collaborator UNKNOWN

  • Fisa Foundation

    collaborator UNKNOWN

  • The Grable Foundation

    collaborator UNKNOWN

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Elizabeth Miller, MD, PhD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-06-01
Completion
2020-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04388696 on ClinicalTrials.gov